- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage IA Non-Small Cell Lung Cancer in Russian Federation
Total 274 results
-
Autonomous Non-Profit Organization National Society...RecruitingStage III Non-small Cell Lung CancerRussian Federation
-
BiocadUnknownNon Small Cell Lung Cancer Stage IIIB | Non-Small Cell Carcinoma of Lung, TNM Stage 4Russian Federation, Belarus
-
Catalysis SLCompletedNon-small Cell Lung Cancer Stage III | Gastric Cancer Stage III | Gastric Cancer Stage II | Non-small Cell Lung Cancer Stage IIKazakhstan, Russian Federation
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerRussian Federation
-
N.N. Blokhin National Medical Research Center of...RecruitingNon Small Cell Lung Cancer | EGFR Gene Mutation | T790MRussian Federation
-
CelgeneCompletedNon-Small Cell Lung Cancer (NSCLC)Russian Federation
-
BiocadActive, not recruitingMelanoma | Non Small Cell Lung CancerRussian Federation
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IVUnited States, Belgium, Bosnia and Herzegovina, Canada, Croatia, Czech Republic, Germany, Poland, Romania, Russian Federation, Serbia, Spain, United Kingdom
-
CytRxTerminatedStage IV Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer With Pleural EffusionUnited States, Mexico, India, Ukraine, Bulgaria, Russian Federation
-
AstraZenecaRecruitingUnresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)Russian Federation
-
Shanghai Henlius BiotechActive, not recruitingExtensive Stage Small Cell Lung CancerChina, Georgia, Poland, Russian Federation, Turkey, Ukraine
-
AstraZenecaRecruitingNon-small-cell Lung CancerRussian Federation
-
NewVac LLCJanssen Pharmaceutica N.V., BelgiumCompletedEpithelial Ovarian Cancer | Non-small Cell Lung CancerRussian Federation
-
Peregrine PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Non-Small-Cell Lung Cancer Stage IIIB | Non-Small-Cell Lung Cancer Stage IV | Non-Small-Cell Lung Cancer MetastaticUnited States, Australia, Belgium, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Ukraine
-
AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCRussian Federation
-
Ascenta TherapeuticsCompletedNon-small Cell Lung CancerRussian Federation, United States, Ukraine
-
UCB PharmaCompletedCarcinoma | Non-Squamous Non-Small-Cell Lung CancerPoland, Russian Federation, Hungary
-
Eli Lilly and CompanyCompletedA Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung CancerNon-Small Cell Lung Cancer Stage IVUnited States, Italy, Spain, Australia, France, Germany, Hungary, Korea, Republic of, Poland, Romania, Russian Federation, Taiwan, Ukraine
-
Eli Lilly and CompanyWithdrawnMetastatic Squamous Non-Small Cell Lung Cancer | Locally Advanced Squamous Non-Small Cell Lung CancerItaly, Romania, Germany, Belgium, Russian Federation, United States, United Kingdom
-
BIND TherapeuticsCompletedNon-small Cell Lung CancerUnited States, Russian Federation
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-Small-Cell Lung AdenocarcinomaUnited States, France, Spain, Netherlands, Czech Republic, Serbia, Romania, Germany, Belgium, Italy, Hungary, United Kingdom, Canada, Poland, Bosnia and Herzegovina, Austria, Slovenia, Croatia, Russian Federation, Ukraine
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerFrance, Canada, United States, Russian Federation, Denmark
-
AstraZenecaCompletedNon-Small Cell Lung CancerRussian Federation
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Spain, Russian Federation, France, Bulgaria, Germany, Estonia, Italy, Poland, Taiwan, United Kingdom, Singapore, Ireland, Belgium
-
Checkpoint Therapeutics, Inc.TerminatedMetastatic Non-squamous Non Small Cell Lung CancerPeru, Russian Federation, South Africa, New Zealand, Georgia, Thailand, Brazil, Malaysia
-
AstraZenecaActive, not recruitingNon Small Cell Lung Cancer (Stage III)United States, Spain, Taiwan, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Hungary, India, Japan, Mexico, Peru, Russian Federation, China, Malaysia, Argentina
-
BIND TherapeuticsCompletedSquamous Cell Non-small Cell Lung Cancer | KRAS Positive Patients With Non-small Cell Lung CancerUnited States, Russian Federation
-
Mabscale, LLCRecruitingNon-Small Cell Lung CancerRussian Federation
-
Ionis Pharmaceuticals, Inc.CompletedNon-small Cell Lung CancerUnited States, Hungary, Poland, Russian Federation
-
BiocadCompletedNon-small Cell Lung CancerUkraine, Belarus, India, Russian Federation
-
Spectrum Pharmaceuticals, IncWithdrawnNon-Small-Cell Lung CarcinomaUnited States, Russian Federation
-
Kidney Cancer Research BureauUnknownNon-small Cell Lung Cancer Metastatic | Pleural Effusion, Malignant | Renal Cell Cancer MetastaticRussian Federation
-
AstraZenecaCompletedNon-small Cell Lung CancerItaly, Poland, France, Spain, United States, Russian Federation
-
AstraZenecaCompletedNon Small Cell Lung CancerRussian Federation
-
Prestige Biopharma LimitedActive, not recruitingLung Cancer | Non-small Cell Lung CancerIndia, Hungary, Georgia, Philippines, Belarus, Bulgaria, Croatia, Greece, Latvia, Malaysia, Poland, Russian Federation, Serbia, Slovakia, Thailand, Turkey, Ukraine
-
Achieve Life SciencesCompletedCarcinoma, Non-Small-Cell LungRussian Federation
-
AstraZenecaActive, not recruitingMetastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, Belgium, Poland, Taiwan, Thailand, Korea, Republic of, Russian Federation, Austria
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerCanada, Netherlands, Spain, France, Japan, Russian Federation, Germany, Belgium, Greece, Turkey, Taiwan, United States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedNon Small Cell Lung CancerUnited States, Poland, Germany, Russian Federation, Latvia, Ukraine
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerChina, Hong Kong, Russian Federation, Singapore
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, France, Germany, Russian Federation, Poland, Italy
-
SanofiCompletedNon-small Cell Lung CancerFrance, Romania, Poland, Croatia, Korea, Republic of, Italy, Chile, United States, Australia, Germany, Russian Federation, Serbia, Ukraine
-
AmgenCompletedExtensive-Stage Small-Cell Lung CancerCanada, United States, Russian Federation
-
Boehringer IngelheimActive, not recruitingNeoplasms | Non-squamous, Non-Small-Cell Lung CancerUnited States, Spain, Korea, Republic of, France, Hong Kong, United Kingdom, Germany, Australia, Taiwan, Poland, Russian Federation, Ukraine
-
Peregrine PharmaceuticalsCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, India, Georgia, Russian Federation, Ukraine
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced or Metastatic Non-Small Cell Lung CancerUnited States, Australia, Brazil, Czech Republic, Russian Federation, Singapore
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVUnited States, Canada, France, Italy, Spain, United Kingdom, Belgium, Poland, Brazil, Germany, Hungary, Peru, Russian Federation, Turkey, Australia, Chile, Austria, Netherlands, Portugal, Israel, Mexico, Romania, Sweden, Ukraine, Bulgaria, Argenti...
-
Axelar ABCompletedNon-small-cell Lung Cancer | Squamous Cell Carcinoma | Adenocarcinoma of the LungRussian Federation, Ukraine, Belarus, Hungary, Poland
-
NewLink Genetics CorporationCompletedNon-Small Cell Lung CancerRussian Federation, Ukraine